Effect of Polygenic Risk Score on Alzheimer's Disease Risk Depends on Age and APOE4 Status

doi 10.1101/2020.04.06.20052332
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Schizophrenia Polygenic Risk Score and Psychotic Risk Detection

The Lancet Psychiatry
PsychiatryBiological PsychiatryMental Health
2017English

Correction: Genetic Assessment of Age-Associated Alzheimer Disease Risk: Development and Validation of a Polygenic Hazard Score

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2017English

Figure 2: Polygenic Risk Score Distribution.

English

The Projected Effect of Risk Factor Reduction on Alzheimer's Disease Prevalence

The Lancet Neurology
Neurology
2011English

PET Sheds Light on Alzheimer's Disease Genetic Risk

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

Alzheimer’s Disease Polygenic Risk Score as a Predictor of Conversion From Mild-Cognitive Impairment

Translational Psychiatry
PsychiatryMolecular NeuroscienceBiological PsychiatryMental HealthCellular
2019English

Common Variants in Alzheimer's Disease: Novel Association of Six Genetic Variants With AD and Risk Stratification by Polygenic Risk Scores

2019English

Using the Framingham Risk Score to Evaluate Immigrant Effect on Cardiovascular Disease Risk in Mexican Americans

Journal of Health Care for the Poor and Underserved
EnvironmentalPublic HealthOccupational Health
2012English

A Weighted Polygenic Risk Score Using 14 Known Susceptibility Variants to Estimate Risk and Age Onset of Psoriasis in Han Chinese

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy